Beta Bionics, Inc. (BBNX) Balance Sheet
As of 2026-06-30 (10-Q), Beta Bionics, Inc. (BBNX) reported total assets of $292.4M, total liabilities of $36.0M and shareholders' equity of $256.4M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $44.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BBNXBeta Bionics, Inc.Follow BBNX — free
—
Price chart with a free account
- Market cap
- 862.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|
| Cash and equivalents | 26.6 | 30.4 | 31.6 | 44.3 | |
| Short-term investments | 70.2 | 73.1 | 187.5 | 136.2 | |
| Receivables | 4.4 | 12.0 | 17.1 | 18.1 | |
| Inventory | 1.2 | 13.3 | 21.7 | 23.9 | |
| Current assets | 103.6 | 132.9 | 267.9 | 231.0 | |
| Total assets | 110.0 | 149.6 | 328.7 | 292.4 | |
| Current liabilities | 10.6 | 21.1 | 30.9 | 26.0 | |
| Total liabilities | 51.4 | 73.6 | 41.1 | 36.0 | |
| Shareholders' equity | -203.1 | -245.4 | 287.6 | 256.4 |
USD millions · SEC XBRL
Beta Bionics, Inc. — questions
- How much cash does Beta Bionics, Inc. have?
- $44.3M in cash and cash equivalents as of 2026-06-30.
- What are Beta Bionics, Inc.'s total assets?
- $292.4M as of 2026-06-30.
- What is Beta Bionics, Inc.'s shareholders' equity?
- $256.4M as of 2026-06-30.
Every figure on this page comes from Beta Bionics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.